Pharma

Taking stock of the drug industry, from the lab to the medicine chest

Opioid Crisis Lawsuits
Pharmalot

Philly city council committee tables ordinance to restrict sales reps after lobbying campaign

By Ed Silverman

Astellas
Pharmalot

Can the pharmaceutical industry really police itself? An episode involving Astellas begs the question

By Ed Silverman

Medical costs
Pharma

A drug that was once inexpensive gets a new price tag: $375,000

By Meghana Keshavan

FDA Drug Labels
Pharmalot

FDA yanks controversial rule to allow generic makers to update product labels

By Ed Silverman

Pharmalot

Pharmalittle: Catalyst will charge $375,000 for rare disease drug; fentanyl is most commonly used drug in overdoses

By Ed Silverman

Worst Biotech CEOs 2017
Adam's Take

And now, your nominees for worst biopharma CEO of 2018. Let the voting begin!

By Adam Feuerstein

Clinical trial meds
Pharmalot

Unconfirmed exploratory trials after approvals may cause too much off-label prescribing

By Ed Silverman

Pharmaceutical production
Pharmalot

Sun Pharma faces a new problem as Indian regulator probes whistleblower charges

By Ed Silverman

Kroger food & drug
Pharma

A grocery chain launches a discount program for prescription drugs. Will patients save money?

By Rebecca Robbins

Pharmalot

Pharmalittle: House moves bill to thwart Medicaid misclassifications; McDonald’s to cut antibiotic use in beef

By Ed Silverman

Best Biotech CEOs 2017
Adam's Take

Introducing the nominees for best biopharma CEO of 2018. Vote for your favorite!

By Adam Feuerstein

Ian Read
Pharmalot

Lawmaker chastises Pfizer for reverting to price hikes next month

By Ed Silverman

CVS Miami
Pharmalot

Pennsylvania auditor recommends new laws to crack down on PBM contracts for Medicaid

By Ed Silverman

Pharmalot

Pharmalittle: What two former Alexion execs are doing now; pharma pushes back on Trump price plan

By Ed Silverman

New Opioid Approved - Dsuvia
The Pharmalot View

The military pushed it for the battlefield. The FDA went along. Is the newest opioid any better?

By Ed Silverman

German pharmacy
Pharmalot

Dozens of groups attack Trump plan to peg drug prices to what other countries pay

By Ed Silverman

Pharmalot

Pharmalittle: Gilead poaches Roche’s CEO; state prosecutors widen generics probe

By Ed Silverman

Hires
Pharmalot

Up and down the ladder: the latest comings and goings

By Ed Silverman

Pharmalot

An FDA inspection report shows just how troubled a Pfizer plant really is

By Ed Silverman

Pharmalot

Pharmalittle: Retail drug spending in the U.S. fell last year; Democrats eye patents to lower drug prices

By Ed Silverman

Pharmalot
Pharmalot

NIH is pressed to ensure affordable pricing before awarding a license for a CAR-T therapy

By Ed Silverman

Pharmalot

A J&J unit pays $360 million for illegally using a charity to pay kickbacks to Medicare patients

By Ed Silverman

Pharmalot

Supreme Court to decide a patent case with big implications for small drug makers

By Ed Silverman

Pharmalot

Pharmalittle: AbbVie cancer program’s setback; Amazon hires a pharmacy expert

By Ed Silverman

Pharmalot

Pharmalittle: Takeda shareholders approve Shire deal; HPV vaccine program in Quebec divides experts

By Ed Silverman

Overprescribing Painkillers
Pharmalot

Investor activists win again and persuade Endo to catalog opioid risks

By Ed Silverman

CVS/Aetna
Pharmalot

CVS boasts that a new pricing model will lower drug costs for health plans. Will it?

By Ed Silverman

NHS
Pharmalot

Will Vertex finally reach a deal with the U.K. over its cystic fibrosis drug?

By Ed Silverman

Foundation Medicine
Biotech

For one cancer patient, biotech’s genetic test turns out to be a ‘lifesaver’

By Jonathan Saltzman — Boston Globe

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy